C1ngal Fertigspritze 1 x 4.0 ml | Osteoarthritis therapy
Kurzbeschreibung:
Brief description:
Breve descripción:
Breve descripción:
Artikel: C1ngal Fertigspritze 1 x 4.0 ml
Hersteller: Anika Therapeutics
Konzentration: HA 88 mg , 18 mg Triamcinolonhexacetonid- Wirkstoff
Packungsinhalt: 1 x 4.0 ml Fertigspritze
Injektionsbereich: Optimal für Gelenke und Leistungsport
Article: C1ngal 1 x 4.0 ml
Manufacturer: Anika Therapeutics
Concentration: HA 88 mg , 18 mg triamcinolone hexacetonide active substance
Package content: 1 x 4.0 ml prefilled syringe
Indication: Optimal for joints and competitive sports
Artículo: C1ngal 1 x 4.0 ml
Fabricante: Anika Therapeutics
Concentración: HA 88 mg , 18 mg de hexacetónido de triamcinolona sustancia activa
Contenido del paquete: 1 x 4.0 ml
Indicación: Óptimo para las articulaciones y los deportes de competición
Article: C1ngal 1 x 4.0 ml
Fabricant: Anika Therapeutics
Concentration: HA 88 mg , 18 mg de substance active triamcinolone hexacétonide
Contenu de l'emballage: 1 x 4.0 ml Fertigspritze
Zone d'injection: Optimale pour les articulations et les sports de compétition
Articolo: C1ngal 1 x 4.0 ml
Produttore: Anika Therapeutics
Concentrazione: HA 88 mg, 18 mg di principio attivo triamcinolone esacetonide
Contenuto dell'imballaggio: 1 x 4.0 ml Siringa pre-riempita
Zona di iniezione: Ottimale per le articolazioni e gli sport competitivi
C1ngal Fertigspritze 1 x 4.0 ml | Osteoarthritis therapy Im Warenkorb
XDas passt dazu
C1ngal Pre-filled Syringes | Osteoarthritis therapy
C1NGAL® is the first combination of hyaluronic acid and cortisone for immediate and long-lasting pain relief in osteoarthritis.
C1NGAL® is a highly effective formulation for the treatment of osteoarthritis. It combines the fast-acting anti-inflammatory and analgesic effects of cortisone tramcinolone hexacetonide with the long-term effects of cross-linked hyaluronic acid, which has the highest active ingredient content, to provide proven, fast and long-term pain relief.
C1NGAL® provides faster pain relief than hyaluronic acid without cortisone. C1NGAL® even works faster than cross-linked hyaluronic acid alone: the C1NGAL® study showed significant pain relief at weeks 1 and 3, as well as long-term pain relief. The progression of pain relief suggests that C1NGAL® may have an even longer effect (well beyond 26 weeks).
Osteoarthritis therapy with C1NGAL:
1+ quality:
- cross-linked hyaluronic acid with highest active ingredient content (88 mg)
- biotechnological manufacturing process of fermentation; free of animal proteins
A plus for patients:
- only 1 injection in the therapy cycle
- fast and long-lasting pain relief as well as improved joint mobility
- ideal for (competitive) athletes and professionals who expect a fast effect and have little time for repeated injections